A comparison of five methods for extracting DNA from paucicellular clinical samples

被引：26

作者：

Cler, Leslie ^{[1
]}

Bu, Dawei ^{[1
]}

Lewis, Cheryl ^{[1
]}

Euhus, David ^{[1
]}

机构：

[1] Univ Texas, Southwestern Med Ctr, Hamon Ctr Therapeut Oncol Res, Div Surg Oncol, Dallas, TX 75390 USA

来源：

MOLECULAR AND CELLULAR PROBES | 2006年 / 20卷 / 3-4期

关键词：

DNA extraction; paucicellular; real-time PCR; methods; cost analysis;

D O I：

10.1016/j.mcp.2005.12.003

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

Translational protocols in cancer and carcinogenesis often require isolation of genomic DNA from paucicellular clinical samples. DNA extraction methods for PCR-based applications should optimize the recovery of amplifiable DNA. We compared five methods for DNA extraction in paucicellular epithelial and lymphocyte samples using proportion of extractions producing amplifiable DNA and mean real-time PCR Ct values for GAPDH as the endpoint measures. The methods included solid-phase DNA adsorption (QIAamp), sequential protein and DNA precipitation (Puregene), magnetic bead adsorption (Dynabeads), phenol-chloroform extraction, and single-step proteinase K digestion. In general, the performance of the three commercial kits was superior to either phenol-chloroform extraction or sin.-le-step protemase K digestion. However, QIAamp and Puregene produced amplifiable DNA more frequently than Dynabeads for starting cell numbers < 50,000. GAPDH Ct values for QIAamp extractions showed the greatest dynamic range and the best linearity across the range of starting cell numbers, but QIAamp was not statistically significantly superior to Puregene. Of the three commercial kits, Puregene is the least expensive. QIAamp and Puregene DNA extraction methods are well-suited for the preparation of paucicellular clinical samples for PCR-based assays. (c) 2006 Elsevier Ltd. All rights reserved.

引用

页码：191 / 196

页数：6

共 26 条

[1]

BANERJEE SK, 1995, BIOTECHNIQUES, V18, P768

[2]

Beaty MW, 1997, CANCER CYTOPATHOL, V81, P180, DOI 10.1002/(SICI)1097-0142(19970625)81:3<180::AID-CNCR8>3.3.CO

[3]

2-1

[4] Detection and quantitation of HER-2 gene amplification and protein expression in breast carcinoma [J].

Bofin, AM ;

Ytterhus, B ;

Martin, C ;

O'Leary, JJ ;

Hagmar, BM .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 122 (01) :110-119

[5]

BU D, 2003, AM ASS CANC RES

[6] Comparison of methods for DNA extraction from paraffin-embedded tissues and buccal cells [J].

Cao, W ;

Hashibe, M ;

Rao, JY ;

Morgenstern, H ;

Zhang, ZF .

CANCER DETECTION AND PREVENTION, 2003, 27 (05) :397-404

[7] Loss of heterozygosity in Benign breast epithelium in relation to breast cancer risk [J].

Euhus, DM ;

Cler, L ;

Shivapurkar, N ;

Milchgrub, S ;

Peters, GN ;

Leitch, AM ;

Heda, S ;

Gazdar, AF .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (11) :858-860

[8]

Gazdar AF, 1998, INT J CANCER, V78, P766, DOI 10.1002/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO

[9]

2-L

[10]

GLASEL JA, 1995, BIOTECHNIQUES, V18, P62

← 1 2 3 →